Fig. 1. a DNA fragmentation (%) in different treatment groups, (b) Agarose gel showing DNA damage by CP and protective effects of Pre and post treatment of AHE and silymarin in pulmonary tissue. Lanes from left (M) low molecular weight marker, (I) control, (II) CP group, (III) AHE (400 mg/kg bw) group, (IV) CP + AHE group, (V) AHE + CP group, (VI) Sily + CP group
Fig. 2. Histopathological effect of cisplatin and protective effect of AHE in rat Lungs. (H&E staining; magnification 40X). Group 1: Lung tissue section from control rats showing normal morphology. Group 2: tissue sections from CP-treated rats show degenerative changes, atrophy and cellular infiltrations. Group 3: Represents lung section from AHE alone treated rats. Group 4: AHE Post-treatment showed mild disorganizations, cellular infiltrations and fibroblast aggregations. Group 5: AHE Pre-treatment showed significant protection against CP-induced lung injury. Group 6: Showed protective effect of Silymarin treatment. AHE- A. hydaspica ethyl acetate fraction, CP-Cisplatin, Br-Bronchioles, As-Alveolar septum, CC-Clara cells, T- Tubules, CI- Cellular infiltrations, DBr-Disorganized bronchioles, FA- fibroblast aggregations, CIEL-collapsed inner epithelial cells
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Afsar et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: